{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T14:06:54Z","timestamp":1780582014549,"version":"3.54.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Foundation for Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.medcli.2026.107408","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T17:19:59Z","timestamp":1773854399000},"page":"107408","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association between different biomarkers and mortality in moderate or asymptomatic severe aortic stenosis: A systematic review"],"prefix":"10.1016","volume":"166","author":[{"given":"Jos\u00e9 Agostinho","family":"Carneiro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Rute","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Ara\u00fajo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2026.107408_bib0205","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.pcad.2014.02.006","article-title":"The global burden of aortic stenosis","volume":"56","author":"Thaden","year":"2014","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.medcli.2026.107408_bib0210","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1161\/CIRCULATIONAHA.119.043391","article-title":"Global, regional, and national burden of calcific aortic valve and degenerative mitral valve diseases, 1990\u20132017","volume":"141","author":"Yadgir","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.medcli.2026.107408_bib0215","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.jacc.2023.05.061","article-title":"ACC\/AHA and ESC\/EACTS guidelines for the management of valvular heart diseases: JACC guideline comparison","volume":"82","author":"Coisne","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.medcli.2026.107408_bib0220","doi-asserted-by":"crossref","first-page":"100201","DOI":"10.1016\/j.shj.2023.100201","article-title":"Asymptomatic severe and moderate aortic stenosis: time for appraisal of treatment indications","volume":"7","author":"Banovic","year":"2023","journal-title":"Struct Heart"},{"key":"10.1016\/j.medcli.2026.107408_bib0225","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1001\/jamacardio.2020.2497","article-title":"Natural history of asymptomatic severe aortic stenosis and the association of early intervention with outcomes: a systematic review and meta-analysis","volume":"5","author":"Gahl","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.medcli.2026.107408_bib0230","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1016\/j.jcin.2022.06.022","article-title":"Impact of moderate aortic stenosis on long-term clinical outcomes: a systematic review and meta-analysis","volume":"15","author":"Coisne","year":"2022","journal-title":"JACC Cardiovasc Interv"},{"issue":"suppl I","key":"10.1016\/j.medcli.2026.107408_bib0235","doi-asserted-by":"crossref","first-page":"I170","DOI":"10.1093\/eurheartjsupp\/suac089","article-title":"Treatment in patients with severe asymptomatic aortic stenosis: is it best not to wait?","volume":"24","author":"Di Pietro","year":"2022","journal-title":"Eur Heart J Suppl"},{"key":"10.1016\/j.medcli.2026.107408_bib0240","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.jcmg.2018.11.026","article-title":"Imaging and impact of myocardial fibrosis in aortic stenosis","volume":"12","author":"Bing","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.medcli.2026.107408_bib0245","doi-asserted-by":"crossref","first-page":"3290","DOI":"10.1161\/CIRCULATIONAHA.104.495903","article-title":"Outcome of 622 adults with asymptomatic, hemodynamically significant aortic stenosis during prolonged follow-up","volume":"111","author":"Pellikka","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.medcli.2026.107408_bib0250","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1136\/heartjnl-2019-316493","article-title":"Sudden cardiac death in asymptomatic patients with aortic stenosis","volume":"106","author":"Minners","year":"2020","journal-title":"Heart"},{"key":"10.1016\/j.medcli.2026.107408_bib0255","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1161\/CIRCHEARTFAILURE.114.001649","article-title":"Natriuretic peptides for risk stratification of patients with valvular aortic stenosis","volume":"8","author":"Parikh","year":"2015","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.medcli.2026.107408_bib0260","doi-asserted-by":"crossref","first-page":"199","DOI":"10.23938\/ASSN.0643","article-title":"Galectin-3 as a novel biotarget in cardiovascular alterations associated to development of severe aortic stenosis","volume":"42","author":"Arrieta","year":"2019","journal-title":"An Sist Sanit Navar"},{"key":"10.1016\/j.medcli.2026.107408_bib0265","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ijcard.2017.06.066","article-title":"ST2 predicts survival in patients undergoing transcatheter aortic valve implantation","volume":"244","author":"Schmid","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.medcli.2026.107408_bib0270","doi-asserted-by":"crossref","first-page":"101875","DOI":"10.1016\/j.eclinm.2023.101875","article-title":"Association of high-sensitivity troponin T with outcomes in asymptomatic non-severe aortic stenosis: a post-hoc substudy of the SEAS trial","volume":"58","author":"Hadziselimovic","year":"2023","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.medcli.2026.107408_bib0275","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.124.035486","article-title":"Circulating plasma proteins in aortic stenosis: associations with severity, myocardial response, and clinical outcomes","volume":"13","author":"Tan","year":"2024","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.medcli.2026.107408_bib0280","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1136\/heartjnl-2015-308873","article-title":"Determinants and prognostic value of Galectin-3 in patients with aortic valve stenosis","volume":"102","author":"Arangalage","year":"2016","journal-title":"Heart"},{"key":"10.1016\/j.medcli.2026.107408_bib0285","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.medcli.2026.107408_bib0290","doi-asserted-by":"crossref","first-page":"4635","DOI":"10.1093\/eurheartj\/ehaf194","article-title":"2025 ESC\/EACTS Guidelines for the management of valvular heart disease: developed by the task force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"46","author":"Praz","year":"2025","journal-title":"Eur Heart J"},{"key":"10.1016\/j.medcli.2026.107408_bib0295","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan \u2013 a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst Rev"},{"key":"10.1016\/j.medcli.2026.107408_bib0300","series-title":"3rd Symposium on Systematic Reviews: Beyond the Basics","article-title":"The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses","year":"2000"},{"key":"10.1016\/j.medcli.2026.107408_bib0305","series-title":"Stata Statistical Software: Release 15.1","year":"2017"},{"key":"10.1016\/j.medcli.2026.107408_bib0310","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.amjms.2021.08.001","article-title":"Adverse outcomes with eccentric hypertrophy in a community based university cohort with aortic stenosis","volume":"362","author":"Lavine","year":"2021","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.medcli.2026.107408_bib0315","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1016\/j.jacc.2014.02.581","article-title":"B-type natriuretic peptide clinical activation in aortic stenosis: impact on long-term survival","volume":"63","author":"Clavel","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.medcli.2026.107408_bib0320","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1002\/ehf2.13946","article-title":"Prognostic relevance of B-type natriuretic peptide in patients with moderate mixed aortic valve disease","volume":"9","author":"Onishi","year":"2022","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.medcli.2026.107408_bib0325","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1136\/heartjnl-2018-313746","article-title":"B-type natriuretic peptide in patients with asymptomatic severe aortic stenosis","volume":"105","author":"Nakatsuma","year":"2019","journal-title":"Heart"},{"key":"10.1016\/j.medcli.2026.107408_bib0330","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11061555","article-title":"Prognostic value of non-invasive global myocardial work in asymptomatic aortic stenosis","volume":"11","author":"Ilardi","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.medcli.2026.107408_bib0335","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2217\/bmm.12.100","article-title":"Diagnostic value of NT-proBNP in identifying impaired coronary flow reserve in asymptomatic moderate or severe aortic stenosis","volume":"7","author":"Banovic","year":"2013","journal-title":"Biomark Med"},{"key":"10.1016\/j.medcli.2026.107408_bib0340","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0249610","article-title":"Outcomes in asymptomatic, severe aortic stenosis","volume":"16","author":"Kvaslerud","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.medcli.2026.107408_bib0345","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1161\/CIRCIMAGING.123.015475","article-title":"Predictors of major adverse cardiovascular events in patients with moderate aortic stenosis: implications for aortic valve replacement","volume":"16","author":"Howard","year":"2023","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.medcli.2026.107408_bib0350","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1016\/j.amjcard.2020.02.004","article-title":"Prognostic value of N-terminal pro-form B-type natriuretic peptide in patients with moderate aortic stenosis","volume":"125","author":"Ito","year":"2020","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.medcli.2026.107408_bib0355","first-page":"156","article-title":"Valvulo-arterial impedance is the best mortality predictor in asymptomatic aortic stenosis patients","volume":"24","author":"Banovic","year":"2015","journal-title":"J Heart Valve Dis"},{"key":"10.1016\/j.medcli.2026.107408_bib0360","first-page":"e35","article-title":"2020 ACC\/AHA guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"143","author":"Otto","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.medcli.2026.107408_bib0365","first-page":"524","article-title":"2021 ESC\/EACTS guidelines for the management of valvular heart disease: developed by the Task Force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"75","author":"Vahanian","year":"2022","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"10.1016\/j.medcli.2026.107408_bib0370","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1161\/01.CIR.95.9.2262","article-title":"Prospective study of asymptomatic valvular aortic stenosis. Clinical, echocardiographic, and exercise predictors of outcome","volume":"95","author":"Otto","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.medcli.2026.107408_bib0375","doi-asserted-by":"crossref","first-page":"4662","DOI":"10.1093\/eurheartj\/ehaf194","article-title":"2025 ESC\/EACTS guidelines for the management of valvular heart disease: developed by the task force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"46","author":"Praz","year":"2025","journal-title":"Eur Heart J"},{"key":"10.1016\/j.medcli.2026.107408_bib0380","doi-asserted-by":"crossref","DOI":"10.15420\/ecr.2021.11","article-title":"Timing of intervention in asymptomatic patients with aortic stenosis","volume":"16","author":"Sevilla","year":"2021","journal-title":"Eur Cardiol"},{"key":"10.1016\/j.medcli.2026.107408_bib0385","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1602\/neurorx.1.2.182","article-title":"Biomarkers: potential uses and limitations","volume":"1","author":"Mayeux","year":"2004","journal-title":"NeuroRx"},{"key":"10.1016\/j.medcli.2026.107408_bib0390","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ahj.2023.11.019","article-title":"Design and rationale of the evaluation of transcatheter aortic valve replacement compared to surveillance for patients with asymptomatic severe aortic stenosis: the EARLY TAVR trial","volume":"268","author":"G\u00e9n\u00e9reux","year":"2024","journal-title":"Am Heart J"},{"key":"10.1016\/j.medcli.2026.107408_bib0395","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ahj.2016.02.001","article-title":"Rationale and design of the Aortic Valve replAcemenT versus conservative treatment in Asymptomatic seveRe aortic stenosis (AVATAR trial): a randomized multicenter controlled event-driven trial","volume":"174","author":"Banovic","year":"2016","journal-title":"Am Heart J"},{"key":"10.1016\/j.medcli.2026.107408_bib0400","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1161\/JAHA.120.017870","article-title":"Comparison of early surgical or transcatheter aortic valve replacement versus conservative management in low-flow, low-gradient aortic stenosis using inverse probability of treatment weighting: results from the TOPAS prospective observational cohort study","volume":"9","author":"Annabi","year":"2020","journal-title":"J Am Heart Assoc"}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775326000588?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775326000588?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T13:39:55Z","timestamp":1780580395000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775326000588"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S0025775326000588"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2026.107408","relation":{},"ISSN":["0025-7753"],"issn-type":[{"value":"0025-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between different biomarkers and mortality in moderate or asymptomatic severe aortic stenosis: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Medicina Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medcli.2026.107408","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107408"}}